- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02467101
Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia (FFA)
Prospective Double-blind, Placebo Controlled Study to Assess the Efficacy of Intralesional Corticoid on the Treatment of Frontal Fibrosing Alopecia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia, that was first described in postmenopausal women, by Kossard in 1994. Since then, FFA has also been reported in premenopausal women and rarely in men.
The exact cause of FFA is unknown. One possible reason can be the disturbed immune response to some component of the scalp hair follicles, however, whether or not the hair loss is caused by hormonal fluctuations is under question. Some authors, consider that FFA is a variant of liquen planopilaris (LPP). Whether FFA is truly an LPP variant or is a distinct entity with shared clinical features remains to be determined. FFA was also diagnosed in family members (mother and daughter) suggesting a possible genetic contribution.
Clinically, it is characterized by progressive frontal and temporoparietal recession of the hairline due to inflammatory destruction of hair follicles. Hair loss occurs in a band-like distribution and the depth of recession can be from 0,5-8 cm. Often, a small number of isolated hairs are spared within the band of alopecia.
Loss of eyebrows (partial or complete) is a finding in FFA and in some cases, can precede the hairline recession. The affected skin is atrophic, shiny, and often lighter than the chronically sun-exposed forehead skin.
The diagnosis of FFA is usually made on the basis of clinical findings, and laboratory tests are rarely required. Dermoscopy, a noninvasive tool can help for the diagnosis of FFA; The dermoscopic features of FFA are: Absence of follicular openings, perifollicular scale, and a feeble perifollicular erythema. Perifollicular erythema at the receding hairline may be a sign of active disease.
Since the first description of FFA, many reports have been published, and the number of new cases of FFA appears to be increasing.
Currently, there are no evidence-based studies to guide treatment and there is no clearly defined line of treatment for the condition. Therefore treatment options vary among clinicians.
The aim of this study is to find if intralesional triamcinolone acetonide (compared to area treated with placebo) may help to halt or slow down the progression of this disease.
The patients are divided into two groups (A and B):
- Group A: right half-head (active border of the disease): treatment with intralesional triamcinolone acetonide left half-head (active border of the disease): placebo (saline solution)
- Group B: right half-head (active border of the disease):placebo (saline solution)
left half-head (active border of the disease): intralesional triamcinolone acetonide
The aim of this study is to find if intralesional triamcinolone may help to halt or slow down the progres- sion of this disease.
All patients provide written informed consent before participating in the study, which is performed according to the Declaration of Helsinki.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rubina Alves, M.D..
- Phone Number: 00351913814831
- Email: rubinaalves@gmail.com
Study Locations
-
-
-
Barcelona, Spain, 08195
- Universitat Internacional Catalunya
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with the diagnosis of Frontal Fibrosing Alopecia
Exclusion Criteria:
- Pregnancy
- Patient unable to accomplishing all fases of treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Corticosteroid/Saline
Corticosteroid/Saline Patients with diagnosis of frontal fibrosing alopecia are included in the study. The diagnosis is based on the clinical findings of frontal and temporoparietal hairline recession with loss of follicular ostia. In the same patient, intralesional triamcinolone acetone will be injected to half-head (in the active border of hairline) and in the other half-head the patient will be injected with saline solution (placebo). The intralesional triamcinolone acetone (40 mg/ml)l) of 0,1 mL/1cm, is given along the frontal and frontoparietal hairline every 4 weeks (3 sessions). This study includes 4 visits: 3 visits of treatment (with 1-month interval) and 1 visit of follow-up (month 6). |
Corticosteroid/Saline Two groups were defined: group A and group B.
Same patient will be injected with intralesional triamcinolone acetonide and a saline solution. Each patient will be injected on half-head.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Phototricogram of two areas of the scalp
Time Frame: 6 months
|
Measuring hair count (number of hairs/0.65 cm2) by comparison with 6 months and baseline
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global photographs of the scalp
Time Frame: 6 months
|
The evaluation of hair growth will be assessed by comparison of standardized images between baseline and 6 months.
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rubina Alves, M.D., Universitat Internacional Catalunya
- Principal Investigator: Juan Antonio Moreno, M.D., Universitat Internacional Catalunya
- Study Director: Ramon Grimalt, M.D.; PhD, Universitat Internacional Catalunya
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UIC-FFA
- UICatalunya (Rubina Alves)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frontal Fibrosing Alopecia
-
Yale UniversityCompletedFibrosing Alopecia | Frontal Fibrosing Alopecia | Central Centrifugal Cicatricial AlopeciaUnited States
-
University of Alabama at BirminghamEli Lilly and CompanyNot yet recruitingFrontal Fibrosing AlopeciaUnited States
-
LEO PharmaCompletedFrontal Fibrosing AlopeciaUnited States
-
Bellevue DermatologyCelgeneUnknownFrontal Fibrosing AlopeciaUnited States
-
University of MinnesotaNot yet recruiting
-
Washington University School of MedicineCompletedFrontal Fibrosing Alopecia | Lichen PlanopilarisUnited States
-
Institute of Dermatology, ThailandEnrolling by invitationFrontal Fibrosing Alopecia | Lichen PlanopilarisThailand
-
University Hospital, BrestTerminatedAlopecia | Lichen PlanusFrance
-
University of MinnesotaCompletedFrontal Fibrosing Alopecia | Central Centrifugal Cicatricial Alopecia | Scarring Alopecia | Central Centrifugal Scarring Alopecia | Lichen PlanopilarisUnited States
-
Massachusetts General HospitalActive, not recruitingFrontal Fibrosing Alopecia | Lichen Planopilaris | Lichen Planopilaris of Scalp | Lichen Plano-PilarisUnited States
Clinical Trials on Corticosteroid/Saline
-
Kuopio University HospitalWithdrawnAtrial FibrillationFinland
-
Kettering Health NetworkRecruiting
-
Ajou University School of MedicineAstraZenecaRecruitingAsthma | Osteoporosis Risk | Osteoporotic Fractures | Osteoporosis, OsteopeniaKorea, Republic of
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
University of FloridaCompleted
-
Lebanese UniversityCompletedCOVID-19 Pandemic | MoralityLebanon
-
Rafael StelmachFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Assiut UniversityNot yet recruiting
-
Randa Abdelbadie AbdelaleemUnknown